标题:NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
作者:Sun, Cheng; Sun, Haoyu; Zhang, Cai; Tian, Zhigang
作者机构:[Sun Cheng] Institute of Immunology, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui China.;[Sun Haoyu] Institute 更多
通讯作者地址:[Zhang, C]Shandong Univ, Sch Pharmaceut Sci, Inst Immunopharmacol & Immunotherapy, Jinan 250100, Peoples R China.
来源:细胞分子免疫学
出版年:2015
卷:12
期:3
页码:292-302
DOI:10.1038/cmi.2014.91
关键词:activating receptor; hepatocellular carcinoma; inhibitory receptor;; natural killer cell; natural killer receptor
摘要:Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer mortality and a common poor-prognosis malignancy due to postoperative recurrence and metastasis. There is a significant correlation between chronic hepatitis B virus (HBV) infection and hepatocarcinogenesis. As the first line of host defense against viral infections and tumors, natural killer (NK) cells express a large number of immune recognition receptors (NK receptors (NKRs)) to recognize ligands on hepatocytes, liver sinusoidal endothelial cells, stellate cells and Kupffer cells, which maintain the balance between immune response and immune tolerance of NK cells. Unfortunately, the percentage and absolute number of liver NK cells decrease significantly during the development and progression of HCC. The abnormal expression of NK cell receptors and dysfunction of liver NK cells contribute to the progression of chronic HBV infection and HCC and are significantly associated with poor prognosis for liver cancer. In this review, we focus on the role of NK cell receptors in anti-tumor immune responses in HCC, particularly HBV-related HCC. We discuss specifically how tumor cells evade attack from NK cells and how emerging understanding of NKRs may aid the development of novel treatments for HCC. Novel mono-and combination therapeutic strategies that target the NK cell receptor-ligand system may potentially lead to successful and effective immunotherapy in HCC.
收录类别:CSCD;SCOPUS;SCIE
WOS核心被引频次:41
Scopus被引频次:47
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928887199&doi=10.1038%2fcmi.2014.91&partnerID=40&md5=f929176193ca9093cec3f1f86b7852c4
TOP